Product Name | MF | CAS | Details |
---|
CaspPro | C20H22N6O2S | 1060253-24-8 | Details |
Carbiphene HCl | C28H35ClN2O2 | 467-22-1 | Details |
CAP-53194 | C21H14N6O5 | 660817-08-3 | Details |
Calcium Fusarate | C20H24CaN2O4 | 21813-99-0 | Details |
Bufetolol | C18H29NO4 | 53684-49-4 | Details |
Bucricaine | C17H22N2 | 316-15-4 | Details |
BPTQ | C17H16N4S | 1802665-43-5 | Details |
BIO-7662 | C38H48N6O8S | 327613-10-5 | Details |
BI-10N | C26H34N6O2S | 1149753-56-9 | Details |
BI1002494 | C23H25N3O5 | 1319738-39-0 | Details |
BGB659 | C29H29F3N4O3 | 1237586-97-8 | Details |
Benzpiperylone | C22H25N3O | 53-89-4 | Details |
BBMP | C12H11BrN2O3S | 97120-13-3 | Details |
AZSMO-23 | C19H13ClN4O | 496793-75-0 | Details |
AT-IAP | C29H40FN5O2 | 1403898-55-4 | Details |
AS6 | C21H32O4S | 1609660-14-1 | Details |
AMG-7980 | C19H22N4O2 | 947192-73-6 | Details |
AMG-7209 | C37H41Cl2FN2O7S | 1623432-51-8 | Details |
AMDE-1 | C18H8ClF6N3 | 478043-30-0 | Details |
Alatrofloxacin | C26H25F3N6O5 | 146961-76-4 | Details |
Alaproclate, (S)- | C13H18ClNO2 | 66171-75-3 | Details |
Agarospirol | C15H26O | 1460-73-7 | Details |
Aganodine | C9H10Cl2N4 | 86696-87-9 | Details |
Afurolol | C15H21NO4 | 65776-67-2 | Details |
Zindoxifene | C21H21NO4 | 86111-26-4 | Details |
8-CSC | C16H15ClN4O2 | 148589-13-3 | Details |
5-Et-ddU | C11H16N2O4 | 108895-49-4 | Details |
Xanthine amine congener trihydrochloride | C21H29ClN6O4 | 2459963-12-1 | Details |
WAY 629 hydrochloride | C15H19ClN2 | 57756-44-2 | Details |
SDM25N hydrochloride | C26H27ClN2O3 | 342884-71-3 | Details |
PSB 11 hydrochloride | C16H18ClN5O | 453591-58-7 | Details |
O-2050 | C23H31NO4S | 1883545-42-3 | Details |
MRS2500 tetraammonium | C13H21IN6O8P2 | 630103-23-0 | Details |
MR 16728 hydrochloride | C23H37ClN2O | 207403-36-9 | Details |
Mesulergine hydrochloride | C18H27ClN4O2S | 72786-12-0 | Details |
Daporinad hydrochloride | C24H30ClN3O2 | 1785666-54-7 | Details |
Asenapine hydrochloride | C17H17Cl2NO | 1261398-77-9 | Details |
(S)-PF-03716556 | C22H26N4O3 | 928774-44-1 | Details |
Amitifadine free base | C11H11Cl2N | 410074-73-6 | Details |
Leuphasyl TFA | C31H40F3N5O9 | 67586-27-0 | Details |
Hypoglycemic agent 1 | C25H24FN5O4 | 2253733-57-0 | Details |
Cys modifier 1 | C18H15N5O5 | 2374314-08-4 | Details |
Codon readthrough inducer 1 | C15H11N3O5 | 1338233-09-2 | Details |
5-TAMRA chloride(91809-66-4 free base) | C25H23ClN2O5 | 125481-77-8 | Details |
VU041 | C19H20F3N3O | 332943-64-3 | Details |
TAS05567 | C21H29N9O2 | 1429038-15-2 | Details |
Taribavirin | C8H13N5O4 | 119567-79-2 | Details |
Seletracetam | C10H14F2N2O2 | 357336-74-4 | Details |
SB-267268 | C22H24F3N3O4 | 205678-26-8 | Details |
(S)-BI-1001 | C19H15BrClNO3 | 957889-73-5 | Details |
RX 67668 | C16H24ClN | 40709-76-0 | Details |
Rhodamine 123 free base | C21H17N2O3+ | 104114-27-4 | Details |
Retosiban | C27H34N4O5 | 820957-38-8 | Details |
PSB-1114 tetrasodium | C10H16F2N2NaO13P3S | 1657025-60-9 | Details |
PS315 | C23H19ClO2 | 1221964-50-6 | Details |
Crizotinib acetate | C23H26Cl2FN5O3 | 877399-53-6 | Details |
Vandetanib Fumarate | C22H24BrFN4O2 | 338992-00-0 | Details |
PKF050-638 | C13H13ClN4O2 | 528893-52-9 | Details |
PCS1055 dihydrochloride | C27H33ClN4 | 361979-40-0 | Details |
Notch inhibitor 1 | C26H25F7N4O3 | 1584647-27-7 | Details |
Irbesartan HCl | C25H29ClN6O | 329055-23-4 | Details |
ML-9 Free Base | C15H17ClN2O2S | 110448-31-2 | Details |
MK-8318 | C27H26F4N2O5 | 1416581-40-2 | Details |
MK-0674 | C26H27F6N3O2 | 887781-62-6 | Details |
MK-0493 | C30H38ClF2N3O2 | 455956-93-1 | Details |
Mcl1-IN-3 | C27H22ClN3O4 | 1814891-79-6 | Details |
LP-922761 | C21H26N6O3 | 1454808-95-7 | Details |
JNJ-46281222 | C23H25F3N4 | 1254980-38-5 | Details |
GNE-0946 | C22H12ClF3N2O4 | 1677667-24-1 | Details |
Gemcitabine elaidate hydrochloride | C27H43F2N3O5.ClH | 2918768-08-6 | Details |
CI 972 anhydrous | C11H12ClN5OS | 115787-68-3 | Details |
CDK8-IN-3 | C22H23N5O2 | 1884500-15-5 | Details |
BRD9185 | C23H21F6N3O2 | 2057420-29-6 | Details |
BMT-090605 | C21H24N4O2 | 1551403-51-0 | Details |
BMS-248360 | C36H45N5O5S | 254737-87-6 | Details |
BI-1950 | C32H26Cl2FN7O3 | 1159724-42-1 | Details |
Levofloxacin sodium | C18H21FN3NaO4 | 872606-49-0 | Details |
Azt-pmap | C20H25N6O8P | 142629-81-0 | Details |
AZD0424 | C25H29ClN6O5 | 692054-06-1 | Details |
Autotaxin-IN-1 | C21H23N7O2 | 1619971-30-0 | Details |
Ascamycin | 91432-48-3 | Details |
AMG-1694 | C23H30F3N3O4S2 | 1361217-07-3 | Details |
3M-011 | C18H25N5O3S | 642473-62-9 | Details |
VHL Ligand 8 | C23H29N3O6 | 2701565-76-4 | Details |
TA-316 | C28H25BrN4O5S2 | 1429321-13-0 | Details |
MAK683-CH2CH2COOH | C23H21FN6O3 | 2639882-68-9 | Details |
LY88074 analog 1 | C25H21NO5S | 183060-99-3 | Details |
Hsp90-Cdc37-IN-1 | C43H57FN2O6S | 2227303-22-0 | Details |
CCG258208 | C24H25FN4O4 | 2055990-90-2 | Details |
FN-1501-propionic acid | C25H27N9O4 | 2408642-48-6 | Details |
Diarylalkane derivative 1 | C34H51NO4 | 191155-65-4 | Details |
AP5 | C28H28FNO4 | 1623194-37-5 | Details |
AN7973 | C19H17BClN3O3 | 1620899-32-2 | Details |
Neurodegenerative Disorder-Targeting Compound 1 | C28H28N4O4 | 1254698-39-9 | Details |
β-glycosidase-IN-1 | C13H23NO5 | 176485-27-1 | Details |
(S)-Purvalanol B | C20H25ClN6O3 | 2310135-61-4 | Details |
ZEN-3862 | C19H17FN2O3 | 1952264-33-3 | Details |
ZEN-3411 | C21H20N4O2 | 1952264-36-6 | Details |
ZEN-3219 | C19H18N2O3 | 1952264-34-4 | Details |
XL-784 free base | C21H22ClF2N3O8S | 1356992-21-6 | Details |
Product Total: Product Page: | ||||
89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 |